Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Maravai Lifesciences Holdings (MRVI) Leases (2021 - 2025)

Maravai Lifesciences Holdings (MRVI) has 5 years of Leases data on record, last reported at $78.6 million in Q4 2025.

  • For Q4 2025, Leases rose 49.57% year-over-year to $78.6 million; the TTM value through Dec 2025 reached $78.6 million, up 49.57%, while the annual FY2025 figure was $78.6 million, 49.57% up from the prior year.
  • Leases reached $78.6 million in Q4 2025 per MRVI's latest filing, up from $52.6 million in the prior quarter.
  • Across five years, Leases topped out at $80.6 million in Q2 2023 and bottomed at $30.3 million in Q1 2023.
  • Average Leases over 5 years is $59.0 million, with a median of $54.1 million recorded in 2022.
  • Peak YoY movement for Leases: soared 70.59% in 2023, then plummeted 30.29% in 2024.
  • A 5-year view of Leases shows it stood at $49.1 million in 2021, then rose by 10.23% to $54.1 million in 2022, then surged by 39.29% to $75.4 million in 2023, then plummeted by 30.29% to $52.6 million in 2024, then soared by 49.57% to $78.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $78.6 million in Q4 2025, $52.6 million in Q4 2024, and $75.4 million in Q4 2023.